Allergan jumps as FDA hints Botox migraine support
by on Aug.02, 2010, under Health and Fitness
Allergan Inc said on Monday U.S. regulators have requested information on how to safely market anti-wrinkle drug Botox to treat migraine headaches, which analysts said suggested the agency may be leaning toward approval of the new indication.
View full post on Yahoo! Health News
